Skip to content

APOE4 astrocytes call the shots on neuronal α-synuclein pathology.

Sep 2026 · Cell Stem Cell · Vol 33 9, pp. 1417-1419 · 0 citations · 10 references
Medicine

TL;DR

The results suggest that APOE4 increases cholesterol levels and impairs lysosomal function in astrocytes, which release pathogenic α-Syn inclusions in APOE4 carriers.

Abstract

In this issue of Cell Stem Cell, Mesentier-Louro et al. use a multi-cellular integrated brain (miBrain) system to uncover mechanisms underlying the accumulation of neuronal α-synuclein (α-Syn) inclusions in APOE4 carriers.1 Their results suggest that APOE4 increases cholesterol levels and impairs lysosomal function in astrocytes, which release pathogenic α-Syn.

View source

Similar papers

Sep 2026

Targeting CH25H restores p62-mediated α-synuclein clearance.

Astrocytes remove extracellular α-synuclein aggregates through p62-dependent autophagy, yet the factors limiting this defense remain unclear. Zhang and colleagues recently identified cholesterol 25-hydroxylase as an inducible negative regulator of p62-mediated clearance. Genetic suppression or a p62-derived decoy pepti...

G. S. Dawe · 0 citations
Review Open access Aug 2026

Rethinking single-pathology therapies by targeting inflammation and co-pathologies in Parkinson’s disease

The known immune response in PD with co-pathology incidence is integrated, highlighting synergistic interactions between α-syn, tau and Aβ and how this promotes a distinct neuroinflammatory response leading to severe neuronal loss and cognitive symptoms.

Jhodi M. Webster, Ashley S. Harms · 0 citations
Case report Open access Oct 2026

In vivo detection of pathologic α- synuclein and TDP-43 in the skin and olfactory mucosa of a patient with Parkinson’s disease-like phenotype carrying the p.Thr272Serfs*10 GRN mutation

We describe a patient carrying the GRN p.Thr272Serfs*10 mutation, who presented with parkinsonism at onset and later developed prodromal frontotemporal dementia, in whom seed amplification assay on olfactory mucosa and skin analyses suggest mixed TDP-43 and α-synuclein co-pathology, highlighting how combining these tec...

P. Caroppo, V. Aprea, C. Villa et al. · 0 citations
Aug 2026

Different lysosomal insults, one microglial fate.

Genetic associations point to a connection between lysosomal function and neurodegeneration. In this issue of Immunity, Balak et al. and Tejwani et al. show that genetically distinct lysosomal insults converge on a shared MITF/TFE-driven epigenetic program that underlies disease-associated microglial states, thereby co...

Bai-Ping Wang, Hui Zheng · 0 citations
Open access Sep 2026

Spreading alpha-synuclein oligomers trigger astrocyte/microglial changes and astrocyte-glutamatergic neuron system dysfunction in an age-related manner

A model in which α-syn oligomer spreading, amplified by aging, simultaneously disrupts the astrocyte–glutamatergic neuron axis and drives microglia into a senescent DAM-like state is proposed, and candidate gene sets for both processes are provided for further investigation of glial dysfunction in PD.

Jaehyun LeeBae, Verena Bopp, Alicia Goreth et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.